through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
We breathe about 20,000 times a day—usually without giving it a second thought. But just like your arms and legs, your lungs and the muscles that power them can be trained. Breathing exercises are not just relaxation techniques; the...
When you exhale, your breath carries far more than carbon dioxide and water vapor. It also contains trace amounts of nitric oxide (NO), a gas produced by inflamed airway tissues. Measuring the concentration of NO in exhaled breath —...
What Is Asthma? Asthma is a chronic condition in which the airways in the lungs become inflamed and narrow, making it difficult to breathe. The disease is characterized by diffuse airway inflammation triggered by a variety of stimuli, res...
Please complete the form to contact our team